Abstract
Background: Hepatitis A Virus (HAV) is a major cause of acute viral hepatitis worldwide, transmitted primarily via the fecal-oral route. In endemic regions, poor sanitation, overcrowding, and unsafe water contribute to sustained transmission. Limited seroepidemiological data exist in northeastern Nigeria, particularly in Jimeta metropolis. Objective: To determine the seroprevalence of HAV-specific IgG and IgM antibodies among patients attending selected hospitals in Jimeta metropolis, Adamawa State, Nigeria, and to assess associated demographic and behavioral risk factors. Methods: A cross-sectional study was conducted among 300 patients attending two hospitals in Jimeta. Sociodemographic and behavioral data were collected using structured questionnaires. Blood samples were tested for HAV IgG and IgM antibodies using ELISA. Data were analyzed using descriptive statistics, Chi-square tests, and logistic regression. Results: The overall HAV IgG seroprevalence was 68% (204/300), indicating widespread prior exposure. IgM positivity was 9.6% (29/300), suggestive of recent infection. Age, household crowding, and consumption of untreated water were significantly associated with IgM positivity (p < 0.05). Logistic regression identified household crowding (OR = 3.1, 95% CI: 1.4–6.7) and untreated water consumption (OR = 2.8, 95% CI: 1.3–6.0) as independent predictors of recent infection. Conclusion: HAV exposure is prevalent in Jimeta metropolis, with evidence of ongoing transmission. Targeted vaccination, improved sanitation, and public health education are recommended to reduce HAV infection and prevent outbreaks.
References
Ageru, T.A. and Abiso, T.L. (2018). Sero-Prevalence of HIV and Syphilis Infection among Pregnant Mothers Attended Labor Ward at Wolaita Sodo University Teaching Referral Hospital, Wolaito sodo, Ethiopia. American Journal of Health Research, 6(3): 67-73.
Gershon, A. A., Gershon, M. D., Breuer, J., Levin, M. J., Oaklander, A. L., & Griffiths, P. D. (2015). Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. Journal of Clinical Virology, 64, 44–49. https://doi.org/10.1016/j.jcv.2015.02.020
Heininger, U., & Seward, J. F. (2006). Varicella. The Lancet, 368(9544), 1365–1376. https://doi.org/10.1016/S0140-6736(06)69575-7
Hofmeister, M.G., Foster, M.A., Teshale, E.H. (2019). Epidemiology and Transmission of Hepatitis A Virus and Hepatitis E Virus Infections in the United States. Cold Spring Harbor Perspectives in Medicine. 2019 Apr 1;9(4): a033431.
Girish, V., Grant, L.M., John, S. (2025). Hepatitis A. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; PMID: 29083664.
Jacobsen, K. H., & Wiersma, S. T. (2010). Hepatitis A virus seroprevalence by age and world region, 1990–2005. Vaccine, 28(41), 6653–6657. https://doi.org/10.1016/j.vaccine.2010.06.058
Obi, S. N., Adeyemo, T., & Ajayi, O. (2021). Hepatitis A virus seroprevalence among children in southwestern Nigeria: Implications for vaccination policy. Nigerian Journal of Paediatrics, 48(1), 34–42.
Ogunjimi, B., Hens, N., & Van Damme, P. (2019). Varicella-zoster virus seroepidemiological in sub-Saharan Africa: A systematic review. Vaccine, 37(37), 5535–5545. https://doi.org/10.1016/j.vaccine.2019.07.022
Olayinka, O. T., Olaleye, D. O., & Fagbo, S. F. (2017). Seroepidemiological of hepatitis A in Nigerian urban populations. African Journal of Medicine and Medical Sciences, 46(2), 95–101.
Papka, I. M., Bukbuk, D. N., Ladan, J., & Babagana, B. (2025a). Serological and molecular detection of hepatitis A virus among women of childbearing age attending some health facilities within Maiduguri metropolis, Borno State, Nigeria. Nigerian Journal of Microbiology, 39(1), 7528–7538.
Papka, I.M., Mala, S.M., Umar, M.M., Ndagiya, A.I., Jeremiah Hussaini, and Paul, Buba. (2025b). Assessment of the effectiveness and safety of Hepatitis A vaccines in the control of hepatitis A virus infection: A global perspective. Impact International Journals and Publications © IIJP 2025 | Volume 1, Issue 4, pp. 207-225 | ISSN: 2636-4484
Sanchez, G. (2021). Hepatitis A virus infection: Epidemiology, prevention, and clinical management. Journal of Clinical Virology, 140, 104844. https://doi.org/10.1016/j.jcv.2021.104844
WHO. (2022). Hepatitis A. Geneva: WHO. Retrieved from https://www.who.int/news-room/fact-sheets/detail/hepatitis-a

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright (c) 2026 AUTHOR
